Hikma Pharmaceuticals Share Discussion Threads

[mikemartin83] 03/3/2015 15:25

Any ideas on why the big drop today?

[rosieoutlook] 01/3/2015 22:19

In today's Sunday Telegraph: Hikma Pharmaceuticals, the Jordanian drug maker, is expected to take the place of Tullow Oil in Britain’s benchmark share index at this week’s quarterly review of FTSE indices

[coppertrader] 26/2/2015 18:44

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, has signed an exclusive license agreement with specialty pharmaceutical company Azanta for its proprietary cancer product Nimoral (nimorazole). Nimoral is a hypoxic radiosensitiser that will enhance the effect of radiotherapy in head and neck cancer patients, said a statement.The product is currently in Phase 3 clinical development and is being made available under named patient programmes throughout the world, it said.Under the terms of the agreement, Hikma will have the exclusive rights to register, manufacture, distribute and market Nimoral in 20 markets in the Middle East and North Africa (Mena) region including Turkey, leveraging Hikma's strong local presence and regulatory expertise, with over 1,800 sales and marketing reps across the region.Mazen Darwazah, Hikma's vice chairman and chief executive of Mena and Emerging Markets, said: "Hikma is committed to improving the treatment of cancer in the Mena region through the development of our oncology product portfolio. "This partnership gives us access to a novel, oral anticancer treatment with excellent potential and reinforces our commitment to growing our portfolio through strong partnerships. We look forward to the Phase 3 results for Nimoral and we are very pleased to be working with Azanta to bring this critically needed therapy to the Mena region."Dr. Claus Møller, chief executive officer of Azanta, said: "We are very pleased to enter this significant agreement with Hikma. We believe Hikma will be an excellent partner for us for Nimoral in the Mena region, which has a population of more than 380 million people or six per cent of the world population." - TradeArabia News Service

[coppertrader] 13/2/2015 13:02

FTSE Quarterly ReviewMeetings to review the constituents of the FTSE100 and FTSE Mid-250 are held on the Wednesday after the first Friday in March, June, September and December. Any constituent changes are then implemented on the next trading day following the expiry of the LIFFE futures and options contracts, which normally takes place on the third Friday of the same month. Promotion/Demotion decisions are based on the companies' relative market capitalisation at the close of business on the Tuesday prior to the Quarterly Review Meeting. The rules the Committee will apply are as follows:

[johnthespacer] 13/2/2015 09:55

When would promotion happen do you think - is the a particular time each month?

[coppertrader] 13/2/2015 08:31

Hik are bouncing around 77th position in the ftse table. Promotion to the ftse100 is very likely with the exception of the share price plumetting.

[karateboy] 11/2/2015 20:13

I guess £24 is becoming support not a resistance ...

[lateralam] 10/2/2015 08:22

Anyone tell me why the big drop yesterday please? Been away for a few days.

[karateboy] 01/2/2015 10:11

Morrison market cap is now £400m less than HIK. So HIK should join Ftsee 100 in the next shuffle...

[karateboy] 30/1/2015 19:01

Who is Myland? But I agree any possible bid should be around £40. Let's hope for that.

[stats11] 29/1/2015 17:55

hxxp://www.fiercepharma.com/story/mylan-said-be-eyeing-7b-plus-bid-rising-star-hikma/2015-01-28

[stats11] 29/1/2015 17:53

wouldn’t be surprised!

[liam1om] 28/1/2015 09:22

Bid speculation today 3900 mentioned from Mylan.

[karateboy] 19/1/2015 18:25

Good day for HIK today. Analysts are expected to upgrade the share if HIK wins its court case in USA which she has now...apostrophe corrected. Thanks

[trewsa] 19/1/2015 09:46

The RSI hit 80-overbought after 10 days going up.
Don't need apostrophe in its.No idea.

[karateboy] 18/1/2015 20:11

HIK shares dropped a bit last few days. I wonder that was due to MRW market cap is being stabilised after the the result. MRW may stay in Ftse. The other issue may be HIK governance. Its chairman and chief executive is the same man. I believe as a condition to enter Ftse 100, these 2 posts should be kept separate...any comments?

[pyemckay] 13/1/2015 15:12

unbelievable momentum.

[broadwood] 13/1/2015 15:05

Unstoppable.

[karateboy] 12/1/2015 22:35

I guess HIK will enter Ftse 100 in the next review...

[jeffcranbounre] 12/1/2015 15:12

Hikma is featured into today's ADFVN podcast.

To listen to the podcast click here>

In today's podcast:

- Technical Analyst Nicola Duke will be chatting and charting, Anite, Big Yellow Group, ITE, Union Jack Oil, Afren. Nicola on Twitter is @NicTrades

- And the micro and macro news including:

Quindell #QPP
Afren #AFR
Shire #SHP
ITV #ITV
Taylor Wimpey #TW.
Big Yellow Group #BYG
ITE #ITE
Union Jack Oil #UJO
Anite #AIE
Unite Group #UTG
Pace #PIC
Royal Mail #RMG
Prudential #PRU
Hikma Pharmaceuticals #HIK
AO World #AO.
Betfair #BET
Sound Oil #SOU
Advanced Oncotherapy #AVO
International Airlines Group #IAG
Afren #AFR
Ophir Energy #OPHR
Premier Farnell #PFL
New River Retail #NRR
Victrex #VCT
Catlin Group #CGL

Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below.



(All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).

Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below:



(Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).

You can subscribe to this podcast in iTunes by clicking

To follow me on Twitter click

As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions:

Bronze - £50 (normally £73.82/year)
Silver - £145 (normally £173.71/year)
Level 2 - £350 (normally £472.94/year)

Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just for more information.

Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing.

Justin

 

 

[broadwood] 12/1/2015 09:29

Yep, looks like FTSE entry.

Takeover activity in the sector today.

[pyemckay] 09/1/2015 14:57

ftse100 entry is looking good short term.

[r ball] 09/1/2015 13:56

nothing else is there?

[broadwood] 09/1/2015 13:11

Strong Buy majority of Brokers who cover .